The lysine residue in the membrane-spanning domain of the beta chain is necessary for cell surface expression of the T cell antigen receptor by unknown
THE LYSINE RESIDUE IN THE MEMBRANE-SPANNING
DOMAIN OF THE R CHAIN IS NECESSARY FOR
CELL SURFACE EXPRESSION OF THE
T CELL ANTIGEN RECEPTOR
By BERNARD J. MORLEY, KINGSLEY N. CHIN, MARIANNE E. NEWTON,
AND ARTHUR WEISS
From the Howard Hughes Medical Institute, Departments of Medicine and of Microbiology and
Immunology, University of California San Francisco, San Francisco, California 94143
TheTCR recognizes antigens associated withMHC molecules (1) . This recogni-
tion event is then transduced across the plasma membrane to initiate intracellular
biochemical events that include phosphatidylinositol hydrolysis and tyrosine kinase
activation (2) . The remarkable complexity of theTCR is likely to have evolved to
carry out efficiently both its recognition and its signal tranduction functions .
TheTCR consists of a molecular complex of at least seven integral membrane
protein chains (Fig . 1) (1-4). On most T cells, theTCR contains a clonally distributed
disulfide-linked heterodimer (Ti) of an a and aR chain, which together are sufficient
for the recognition of both antigen and the restrictingMHC molecule (5, 6) .Adis-
tinct form of Ti consisting ofay/S chain heterodimer is present on a subpopulation
ofT cells but its function is unknown (7, 8) .
Associated with both forms of Ti are at least five invariant peptide chains com-
posing theCD3 complex, the CD3-S, -e, -7, anddisulfide-linked ~chains (2-4) . Some
TCR complexes may contain a ~ chain that is disulfide-linked to another protein
referred to as theCD3 rl chain (9) . The short cytoplasmic tails of Ti chains (5-12
residues) compared with theextensive cytoplasmic domains of theCD3 chains (40-113
residues) (1-4, 10), the agonist properties ofCD3mAbs (reviewed in references 2-4),
and studies with somatic cell mutants (11), suggest that CD3 plays a role in signal
trandduction .
The nature of the structural and functional association between the Ti andCD3
subunits is of considerable interest. Cointernalization (12), coimmunoprecipitation
(13), and crosslinking studies (14) have demonstrated their association on the cell
surface . Studies with somatic cell mutants have established that the cell surface ex-
pression ofCD3 is dependent upon the Ti heterodimer (15) . Individual chains of
CD3 can also limit cell surface expression of the entire TCR complex as evidenced
in studies with CD3 ~ chain-deficient cells (16) . The variable influence ofdetergent
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concentration upon preservation of CD3 and Ti association suggests that hydro-
phobic protein domains and/or protein-phospholipid interactions may be impor-
tant in the C133 -Ti association (17). One striking structural feature of the deduced
primary sequence of all of the component Ti and CD3 chains that may relate to
their structural and functional association is the unusual conservation of charged
residues within their transmembrane domains (2-4, 10). Basic lysine and arginine
residues are present in all four ofthe Ti chains (a, a, y, and S), and acidic glutamic
or aspartic residues are present in the CD3-S, -e, -y, and -~ chains (Fig. 1). It has
been proposed that these unusually placed oppositely charged residues are respon-
sible for the CD3Ti association, perhaps through salt bridges. The transmembrane
lysine residue in the Ti-R chain is conserved in human (18), murine (19), feline (20),
and rabbit species (21). Using a R chain-deficient mutant of the human T cell line
Jurkat, we used site-directed mutagenesis to examine the importanceof this residue.
Materials and Methods
Cells.
￿
The human T cell line Jurkat and a mutant ofJurkat, J.RT3T3.5, which fails to
express the TCR complex due to deficient full-length Ti R chain transcription, were previ-
ously described (15).
Mutagenesis.
￿
A 2 .2-kb Xbal-Barn HI fragment from pFoFneo (15), containing the wild-
type Ti a chain cDNA, was ligated into M13mp10. Site-directed mutagenesis was carried
out usingthe double primer approach (22). All mutant clones were then sequenced by the
dideoxynucleotide method (23) to ensure that no other changes had been introduced. Once
a mutant containing the desired base change was isolated, the replicative form ofthe M13mp10
was isolated using the alkaline-lysis method for plasmid preparation (23) and the 2.2-kb Xbal-
Bam HI fragment was re-excised . A pTOFneo derivative, p1glob, was prepared by substituting
a 600-bp 0 globin fragment for the 2.2-kb Ti d chain cDNA. The mutant Ti R chain cDNA
fragments were then religated into this vector. Thus, any recircularization of the vector with
its own insert could be readily distinguished from plasmids containing mutant Ti (3 chain
cDNA inserts.
Transfections.
￿
J.RT3T3.5 cells were transfected with plasmid DNA by protoplast fusion
or electroporation as previously described (11, 15). Transformants were selected for by resis-
tance to geneticin (2 mg/ml; Sigma Chemical Co., St. Louis, MO).
RNA Analyses.
￿
Geneticin-resistant clones were screened by RNA dot-blot analysis and
Northern blot analysis using the full-length R chain cDNA (15), the Xbal-Pvu II fragment
of the Jurkat Vg cDNA, or the full-length Jurkat a chain cDNA (24).
Briefly, cytoplasmic extracts ofcells were prepared by lysing cells in a solution containing
0.5% NP-40 in 10 mM Tris (pH 7.0), 1 mM EDTA and sedimenting the particulate fraction.
50 p1 of supernatant derived from 1-2 x 106 cells were diluted with 30 ul of 20 x SSC (3 M
NaCl, 0.3 M trisodium citrate, pH 7.0) and 20 Al of 37% formaldehyde. The mixture was
heated at 60°C for 15 min and either frozen or used immediately in a dot-blot manifold ap-
paratus (Hoefer Scientific Instruments, San Francisco, CA). Serial dilutions of cell extracts
were aspirated onto nylon filters and hybridized as previously described. Geneticin-resistant
clones hybridizing with theJurkat Vs cDNA probe were further analyzed by Northern blot
analysis.
RNA for Nothern blot analyses was isolated by either the guanidinium thiocyanate method
(23) or by the following method for large numbers of samples. Cells were lysed by vortexing
in lysis buffer (0.65% NP-40; 10 mM Tris, pH 7 .8; 1.5 MM MgC12; 150 mM NaCI). Nuclei
and large cell fragments were pelleted by low-speed centrifugation and the resulting superna-
tant was treated with an equal volume of 7 M urea; 1% SDS; 10 mM Tris, pH 7 .5; 10 mM
EDTA; 350 mM NaCl, and incubated for 10 min on ice. The solution was then extracted
with phenol and RNA was precipitated with 2.5 vol of ethanol. Northern blotswere prepared
and hybridized as previously described (15).
Immunofluorescence andFlow Cytometry.
￿
Cells were stained by indirect immunofluorescenceMORLEY ET AL .
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with the indicatedmAb as previously described (11, 17) . Cell surface immunofluorescence
was assessed by flow cytometry using the FACScan (Becton Dickinson & Co., Mountain
View, CA) .
Protein Sequence Analysis.
￿
The Chou-Fassman algorithm (25) to predict secondary protein
structure was performed using software available from Intelligenetics, Inc . (Mountain
View, CA) .
Results and Discussion
Conservation of oppositely charged aminoacid residues within thetransmembrane
domains of the chains of the Ti heterodimers and CD3 complex (Fig. 1) has been
observed in all of the chains ofthe complexthat have been cloned to date (reviewed
in references 2-4) . To assess the function of these unusually placed acidic and basic
residues, site-directed mutagenesis was performed of the lysine residue within the
Ti R chain transmembrane domain, lysine 29° (26) .
We utilized as the recipient cell in these transfection experiments a mutant of the
human T cell line Jurkat, J.RT3T3.5, that fails to express substantial levels of cell
surface CD3 or the Ti heterodimer due to deficient expression of full-length 1 .3-kb
Ti 0chain transcripts (15) .J.RT3T3 .5 still transcribes the nonfunctionally rearranged
1.0-kb transcript, resulting from aD-j rearrangement only, derived from the other
allele (18) . High level expression of both CD3 and the Ti heterodimer can be re-
stored by expression ofawild-typeTi R chaincDNA that is constitutively transcribed
under the influence of the Friend spleen focus-forming virus long-terminal repeat
in pT(3F-neo (15).
The Ti R chain lysine29° was mutagenized to arginine, glutamic acid, glutamine,
serine, or leucine . J.RT3T3 .5 was transfected by protoplast fusion or electropora-
tion with thepTPF-neo containing the wild-type Ti (3 chain sequence or the mutants
at position 290 . These plasmids also contain the neomycin resistance gene. At least
12 independent geneticin-resistant clones ofeach plasmid transfection were screened
byRNAdot-blot or Northern analyses . In each transfection, at least 5070 ofgeneticin-
resistant cells expressed a new 3.4-kb Ti R chain transcript . Whereas all cells con-
tained the 1.0-kb Ti R chain transcript, only transfected cells contained the 3.4-kb
transcript, which hybridizes with the Vp cDNA probe (unlike the 1.0-kb transcripts,
whichlackV region sequence [18])and serves as aconvenient marker fortranscripts
derived from the transfected cDNA . The larger transcript size results from the use
FIGURE 1 .
￿
Schematic model of
the humanTcell antigen letters.
The single letter code for amino
acids was used to designate
charged residues within the
membrane-spanning domains .1974
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ofadownstream polyadenylation addition site in the expression vector (15) .A Northern
blot analysis of representative clones is depicted in Fig. 2.
All clones expressing the3.4-kb transcript were then analyzed for cell surface receptor
expression by immunofluorescence and flow cytometry using the following mAbs :
anti-Leu-4 (anti-CD3) ; WT31 (anti-Tia10); and C305 (antiTi, Jurkat 0 chain spe-
cific) .Aconsistent phenotype was observed using all three antibodies with all trans-
fected cells . Examples of these findings obtained with anti-Leu-4 and WT31 are
presented in Fig . 3 using the same clones of cells depicted in Fig . 2 that expressed
abundant levels of the 3.4-kb transcript . High level cell surface expression of both
the Ti heterodimer and CD3 could only be restored by the construct containing
FIGURE 2 .
￿
Northern blots of RNA
isolated from Jurkat cells (lane 1), S
chain-deficient mutant J.RT3T3.5,
which served as the recipient in trans-
fections (lane 2), and transfectants
(lanes 3-9). A single letter superscript
is used to designate the mutations at
position 290from the wild-type lysine
residue. The transfectant in lane 9
represents a cell transfected withcDNA
in which the argininemmutantcDNA
served as a template to back-mutate
that residue to lysine using the AAA
codon. Blots were hybridized with a
full-length Ti a chain cDNA probe
(A), a Vg-specificcDNA probe (B) or
a full-length Ti a chain probe (C) .a w
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FIGURE 3. Flow cytometry
histograms of ,jurkat (A),
chain-deficientmutantJ.RT3-
T3.5 (0-; B), which served as
the recipient in transfections,
andtransfectants(C-I)stained
with the following mAbs: IgG
control (dotted lines); WT31,anti-
Ti al0 (thin solidlines); or anti-
Leu-4, anti-CD3 (thick solid
Asingle letter superscript
is used to denote the mutation
at lysine290.
the wild-type sequence (Fig. 3 C), i.e., lysine at residue 290. In contrast, cells ex-
pressing arginine, glutamine, glutamic acid, leucine, or serine residues at position
290 failed to express appreciable levels of the TCR on the cell surface as assessed
by immunofluorescence with any of the three mAbs used that react with distinct
antigenic determinants ofCD3 or Ti (Fig. 3, D-H). The use of three mAbs that
react with distinct determinants of the CD31Ti complex argues that the failure to
detect the CD3 or Ti onthe cell surfacewas notdueto TCR conformational changes
induced by the mutated transmembrane residue.
Levels of3.4-kb transcripts varied among clones but failure ofexpression ofcell
surface ofCD3 and Ti could not be attributed to thesedifferences since lower levels
of transcripts derived from wild-type cDNA transfectants still restored abundant
levels ofCD3 and Tion the cell surface(data not shown). To rule out the possibility
oferrors in mutagenesis, such assecond sitemutations, thecDNAconstruct contain-
ing the arginine2s° mutation was used as a template. Arginine290 was back-mutated
to lysine using the alternate codon for lysine, AAA, rather than AAG contained
in the wild-type cDNA. This construct did reconstitute cell surface expression of
CD3 and Ti determinants (Fig. 3 I).
These results strongly argue that the lysine residue at position 290 within the Ti
0 chain transmembrane domain is critical for TCR expression. This is consistent
with the observed conservation oflysine atthis position in human, murine, rabbit,
and feline Ti R chains (18-21). It has been proposed that the basic residue at this
position may be important in the association with CD3 chains, which all contain
acidic residues in their transmembrane domains. The failure ofthe basic arginine
residue to substitute for lysine suggests that side chain structure, as well as charge,
may be an important determinant at this residue. Since the structure ofthe trans-
membrane domain of the Ti 0 chain is not known, we used a Chou-Fassman al-
gorithm (25) to predict the secondary structure ofthis domain. The value ofsuch
predictions for protein transmembrane domains is not known. Nevertheless, at
lysine29° in the wild-type 0 chain, a transition from 0-pleated sheet to a helix is
A JURKAT
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predicted to occur. At this position the algorithm predicts that glutamic acid, but
not arginine, preserves this transition in structure. However, the failure of glutamic
acid to reconstitute CD3/Ti expression suggests that secondary structure may not
be the only important feature. Since such charged residues are unusual in trans-
membrane domains, we also mutated this residue to serine and leucine, residues
commonly expressed within transmembrane domains. These mutant cDNAs, like-
wise, failed to restore CD3/Ti expression. Accordingto the Chou-Fassman algorithm
(25), these changes would have altered the predicted transition in secondary struc-
ture occurring in the wild-type protein at position 290.
The dynamic assembly of theCD3/Ti has received considerable recent attention
(4). The failure of the arginine or other substitutions to reconstitute CD3/Ti could
be due to the instability of the mutant S chain proteins. However, biosynthetic
labeling studies of the cells transfected with the Ti R chain cDNA containing the
arginine mutation suggest that the Ti 0 chain protein is synthesized at levels com-
parablewith thoseobserved with thewild-typecDNA (datanot shown). Association
between the CD3 complex and the arginine"° mutant Ti R chain protein has not
been observed in preliminary biosynthetic labeling studies. This suggests that lysine
at position 290 may be important at an early step in the assembly of the CD3/Ti
complex.
The TCR represents one of the most complex plasma membrane receptors de-
scribed to date. The Ti structure appears to function primarily as a ligand-binding
subunit, and the associated CD3 complex is thought to be involved in a signal-
transducing function perhaps by coupling the occupied Ti subunit to the intracel-
lular signal transduction mechanism. Indeed twodistinct alternative ligand binding
subunits, Ti a/R and Ti r/S, are coupled to CD3. A striking structural feature of
the component chains is the conserved transmembrane charged residues. This study
would suggest that, at least in the case of the Ti R chain, conservation of structural
features of these transmembrane residues, in addition to charge properties, are im-
portant.
The function of these charged residues has been attributed to the structural as-
sociation of the Ti subunit to CD3. In view of the relatively rigid constraints for
conservation of the lysine within the Ti a chain membrane-spanning domain, one
may speculate upon additional functions of these transmembrane domains. The
transfer of information across the plasma membrane to signal the cytoplasmic do-
main of receptor occupancy is an issue of considerable importance. One possible
mechanism to accomplish such information transfer is to change conformationally
the relationship between interacting charged amino acids within the plasma mem-
brane. This function would likely impose constraints upon the structural features
of the transmembrane domains to allowappropriate chain interactions. This would
be consistent with the observed conservation across species for the lysine residue
of the Ti R chain at position 290. In this regard, it is noteworthy that other physio-
logically active receptorswith multiple transmembrane-spanning domainsalso con-
tain charged residues. The family of receptors homologous with the 02 adrenergic
receptor, which interact with GTP-bindingproteins, have seventransmembrane span-
ning domains, some with conservedcharged residues like the TCR, albeit the seven
membrane-spanning domains are contained within a single polypeptide chain (27).Hence, these receptors may utilize a common mechanism for transducing a state
of receptor occupancy to cytoplasmic domains to initiate intracellular responses.
Summary
The TCR is a complex receptor composed of seven polypeptide chains consisting
of a ligand-binding subunit, Ti, and a putative signal-transducing subunit, CD3 .
Phylogeneticaily conserved charged amino acid residues within the membrane-
spanning domains present in all seven chains of the TCR have been proposed to
be important in the association between Ti and CD3 . Using a Ti a chain-deficient
mutant of the cell line Jurkat, site-directed mutagenesis and transfection of Ti R
chain cDNA was performed to assess the importance ofthe lysine residue at position
290 within the membrane-spanning domain of the Ti R chain to expression of the
TCR complex. These studies demonstrated that the lysine residue, and not simply
conservation ofeither basic charge or secondary structure, is important at this position.
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